Ingevity is trying to complete a cup without handle with a 56.30 entry. See if the stock can clear the breakout price in ...

Deckers is the IBD Stock Of The Day as it sprints past a buy point to a new high amid robust earnings and a positive analyst ...

IBD is managed by Inspire. IBD ... corporate bonds issued by some of the most inspiring large cap blue chip companies in the United States. Investors should also pay attention to an ETF's expense ...

A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...

Technically, that makes Nvidia stock a buy. But investors who follow the IBD Methodology and realize there's earnings risk ...

Vertiv stock shares have risen 175% as of November 11. Last month, the data center hardware and services provider exceeded ...

Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions.

A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral ...

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...

A peptide hormone produced in the brain that triggers physiological reproductive responses has been 'hacked' by scientists to ...